These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36029126)

  • 21. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs.
    Katrekar D; Yen J; Xiang Y; Saha A; Meluzzi D; Savva Y; Mali P
    Nat Biotechnol; 2022 Jun; 40(6):938-945. PubMed ID: 35145312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pCEC-red: a new vector for easier and faster CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Maestroni L; Butti P; Senatore VG; Branduardi P
    FEMS Yeast Res; 2023 Jan; 23():. PubMed ID: 36640150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in precise regulation of CRISPR/Cas9 gene editing technology.
    Cao JX; Wang YL; Wang ZX
    Yi Chuan; 2020 Dec; 42(12):1168-1177. PubMed ID: 33509781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the Precision of Base Editing by Bubble Hairpin Single Guide RNA.
    Hu Z; Wang Y; Liu Q; Qiu Y; Zhong Z; Li K; Li W; Deng Z; Sun Y
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs.
    Qu L; Yi Z; Zhu S; Wang C; Cao Z; Zhou Z; Yuan P; Yu Y; Tian F; Liu Z; Bao Y; Zhao Y; Wei W
    Nat Biotechnol; 2019 Sep; 37(9):1059-1069. PubMed ID: 31308540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs.
    Sun YJ; Chen WD; Liu J; Li JJ; Zhang Y; Cai WQ; Liu L; Tang XJ; Hou J; Wang M; Cheng L
    Angew Chem Int Ed Engl; 2023 Jan; 62(5):e202212413. PubMed ID: 36453982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
    Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
    BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imperfect guide-RNA (igRNA) enables CRISPR single-base editing with ABE and CBE.
    Zhao D; Jiang G; Li J; Chen X; Li S; Wang J; Zhou Z; Pu S; Dai Z; Ma Y; Bi C; Zhang X
    Nucleic Acids Res; 2022 Apr; 50(7):4161-4170. PubMed ID: 35349689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient genome editing using tRNA promoter-driven CRISPR/Cas9 gRNA in Aspergillus niger.
    Song L; Ouedraogo JP; Kolbusz M; Nguyen TTM; Tsang A
    PLoS One; 2018; 13(8):e0202868. PubMed ID: 30142205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.